1. Home
  2. LAZ vs IDYA Comparison

LAZ vs IDYA Comparison

Compare LAZ & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lazard Inc.

LAZ

Lazard Inc.

N/A

Current Price

$38.45

Market Cap

3.4B

Sector

Finance

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$31.95

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAZ
IDYA
Founded
1848
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.6B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
LAZ
IDYA
Price
$38.45
$31.95
Analyst Decision
Hold
Strong Buy
Analyst Count
10
16
Target Price
$43.00
★ $52.38
AVG Volume (30 Days)
★ 1.7M
806.6K
Earning Date
10-22-2026
11-10-2026
Dividend Yield
★ 5.06%
N/A
EPS Growth
N/A
★ 61.90
EPS
★ 1.20
N/A
Revenue
★ $3,186,466,000.00
$218,710,000.00
Revenue This Year
$6.00
N/A
Revenue Next Year
$19.51
$188.45
P/E Ratio
$32.95
★ N/A
Revenue Growth
1.48
★ 3024.43
52 Week Low
$34.13
$26.81
52 Week High
$58.75
$42.68

Technical Indicators

Market Signals
Indicator
LAZ
IDYA
Relative Strength Index (RSI) 54.35 34.28
Support Level $34.65 $29.74
Resistance Level $45.71 $31.95
Average True Range (ATR) 1.59 1.54
MACD 0.46 -0.17
Stochastic Oscillator 68.76 3.66

Price Performance

Historical Comparison
LAZ
IDYA

About LAZ Lazard Inc.

Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: